These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 28408703)

  • 1. Accuracy of
    Brophey MD; Farukhi IM; Castanon R; DeLaPena R; Bradshaw L; Banerjee S
    J Nucl Med Technol; 2017 Jun; 45(2):75-81. PubMed ID: 28408703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of obstructive coronary artery disease using regadenoson stress and 82Rb PET/CT myocardial perfusion imaging.
    Hsiao E; Ali B; Blankstein R; Skali H; Ali T; Bruyere J; Kwong RY; Di Carli MF; Dorbala S
    J Nucl Med; 2013 Oct; 54(10):1748-54. PubMed ID: 23940305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the prognostic value of normal regadenoson with normal adenosine myocardial perfusion imaging with propensity score matching.
    Iqbal FM; Hage FG; Ahmed A; Dean PJ; Raslan S; Heo J; Iskandrian AE
    JACC Cardiovasc Imaging; 2012 Oct; 5(10):1014-21. PubMed ID: 23058068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized Comparison of Clinical Effectiveness of Pharmacologic SPECT and PET MPI in Symptomatic CAD Patients.
    Patel KK; Al Badarin F; Chan PS; Spertus JA; Courter S; Kennedy KF; Case JA; McGhie AI; Heller GV; Bateman TM
    JACC Cardiovasc Imaging; 2019 Sep; 12(9):1821-1831. PubMed ID: 31326480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The reproducibility and prognostic value of serial measurements of heart rate response to regadenoson during myocardial perfusion imaging.
    Andrikopoulou E; AlJaroudi WA; Farag A; Lester D; Patel H; Iskandrian AE; Hage FG
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1493-502. PubMed ID: 27079736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease.
    Doukky R; Fughhi I; Campagnoli T; Wassouf M; Ali A
    J Nucl Cardiol; 2017 Feb; 24(1):112-118. PubMed ID: 26582040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of vasodilator response using rubidium-82 positron emission tomography myocardial perfusion imaging in patients with coronary artery disease.
    Arasaratnam P; Sadreddini M; Yam Y; Kansal V; Dorbala S; Di Carli MF; Beanlands RS; Merhige ME; Williams BA; Veledar E; Min JK; Chen L; Ruddy TD; Germano G; Berman DS; Shaw LJ; Chow BJW
    Eur J Nucl Med Mol Imaging; 2018 Apr; 45(4):538-548. PubMed ID: 29177706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac Displacement During
    Vleeming EJ; Lazarenko SV; van der Zant FM; Pan XB; Declerck JM; Wondergem M; Knol RJJ
    J Nucl Med Technol; 2018 Jun; 46(2):114-122. PubMed ID: 29273695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of post-stress decrease in left ventricular ejection fraction in patients undergoing regadenoson stress gated SPECT myocardial perfusion imaging.
    Gomez J; Golzar Y; Fughhi I; Olusanya A; Doukky R
    J Nucl Cardiol; 2018 Aug; 25(4):1313-1323. PubMed ID: 28181156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of Rb-82 positron emission tomography myocardial perfusion imaging in coronary artery bypass patients.
    Pen A; Yam Y; Chen L; Dorbala S; Di Carli MF; Merhige ME; Williams BA; Veladar E; Min JK; Pencina MJ; Berman DS; Beanlands RS; Shaw LJ; Chow BJ
    Eur Heart J Cardiovasc Imaging; 2014 Jul; 15(7):787-92. PubMed ID: 24477784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the prognostic value of regadenoson and adenosine myocardial perfusion imaging.
    Farzaneh-Far A; Shaw LK; Dunning A; Oldan JD; O'Connor CM; Borges-Neto S
    J Nucl Cardiol; 2015 Aug; 22(4):600-7. PubMed ID: 25987234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regadenoson versus Dipyridamole: A Comparison of the Frequency of Adverse Events in Patients Undergoing Myocardial Perfusion Imaging.
    Amer KA; Hurren JR; Edwin SB; Cohen G
    Pharmacotherapy; 2017 Jun; 37(6):657-661. PubMed ID: 28475259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of ischemic electrocardiographic changes with regadenoson stress myocardial perfusion imaging.
    Doukky R; Nigatu A; Khan R; Anokwute C; Fughhi I; Ayoub A; Iskander F; Iskander M; Kola S; Sahyouni M; Karavolos K; Hota BN; Gomez J
    J Nucl Cardiol; 2020 Oct; 27(5):1521-1532. PubMed ID: 30132187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of regadenoson stress myocardial perfusion imaging in patients with left bundle branch block or ventricular paced rhythm.
    Iskander F; Iskander M; Gomez J; Doukky R
    J Nucl Cardiol; 2021 Jun; 28(3):967-977. PubMed ID: 31144225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF.
    Dorbala S; Hachamovitch R; Curillova Z; Thomas D; Vangala D; Kwong RY; Di Carli MF
    JACC Cardiovasc Imaging; 2009 Jul; 2(7):846-54. PubMed ID: 19608135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of regadenoson-induced myocardial creep on dynamic Rubidium-82 PET myocardial blood flow quantification.
    Koenders SS; van Dijk JD; Jager PL; Ottervanger JP; Slump CH; van Dalen JA
    J Nucl Cardiol; 2019 Jun; 26(3):719-728. PubMed ID: 30788758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography?
    Yoshinaga K; Chow BJ; Williams K; Chen L; deKemp RA; Garrard L; Lok-Tin Szeto A; Aung M; Davies RA; Ruddy TD; Beanlands RS
    J Am Coll Cardiol; 2006 Sep; 48(5):1029-39. PubMed ID: 16949498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the myocardial blood flow response to regadenoson and dipyridamole: a quantitative analysis in patients referred for clinical 82Rb myocardial perfusion PET.
    Goudarzi B; Fukushima K; Bravo P; Merrill J; Bengel FM
    Eur J Nucl Med Mol Imaging; 2011 Oct; 38(10):1908-16. PubMed ID: 21656246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk stratification with vasodilator stress SPECT myocardial perfusion imaging in patients with elevated cardiac biomarkers.
    Gowdar S; Ahlberg AW; Rai M; Perucki WH; Felpel KD; Savino JA; Alter EL; Henzlova MJ; Duvall WL
    J Nucl Cardiol; 2020 Dec; 27(6):2320-2331. PubMed ID: 30815834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial experience with regadenoson stress positron emission tomography in patients with left bundle branch block: Low prevalence of septal defects and high accuracy for obstructive coronary artery disease.
    Meredith D; Cremer PC; Harb SC; Xu B; Mentias A; Jaber WA
    J Nucl Cardiol; 2021 Apr; 28(2):536-542. PubMed ID: 30877551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.